Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)

We evaluated the efficacy and safety of nivolumab and eribulin combination therapy for metastatic breast cancer (BC) in Asian populations.

Source: European Journal of Cancer - October 14, 2023 Category: Cancer & Oncology Authors: Se Hyun Kim, Seock-Ah Im, Koung Jin Suh, Kyung-Hun Lee, Min Hwan Kim, Joohyuk Sohn, Yeon Hee Park, Ji-Yeon Kim, Jae Ho Jeong, Kyoung Eun Lee, In Sil Choi, Kyong Hwa Park, Hee-Jun Kim, Eun Kyung Cho, So Yeon Park, Milim Kim, Jee Hyun Kim Source Type: research